ANG Lifesciences India Limited (BOM:540694)
35.73
-0.21 (-0.58%)
At close: Jul 27, 2026
ANG Lifesciences India Market Cap
ANG Lifesciences India has a market cap or net worth of 472.58 million as of July 28, 2026. Its market cap has increased by 15.66% in one year.
Market Cap
472.58M
Enterprise Value
1.23B
Revenue
862.13M
Ranking
n/a
PE Ratio
n/a
Stock Price
35.73
ChartMarket Cap Chart
Since September 8, 2017, ANG Lifesciences India's market cap has decreased from 497.60M to 472.58M, a decrease of -5.03%. That is a compound annual growth rate of -0.58%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 28, 2026 | 472.58M | 22.47% |
| Dec 31, 2025 | 385.87M | -33.77% |
| Dec 31, 2024 | 582.66M | -35.72% |
| Dec 29, 2023 | 906.38M | -42.23% |
| Dec 30, 2022 | 1.57B | -67.78% |
| Dec 31, 2021 | 4.87B | 1,136.05% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Sep 8, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Phaarmasia | 640.85M |
| Asston Pharmaceuticals | 531.63M |
| Biofil Chemicals and Pharmaceuticals | 527.27M |
| Shelter Pharma | 450.55M |
| Vista Pharmaceuticals | 438.25M |
| Mangalam Drugs & Organics | 427.36M |
| Rajnish Wellness | 416.29M |
| Parmax Pharma | 400.17M |